According to Dare Bioscience
's latest financial reports the company has $3.63 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $34.66 M | -32.91% |
2021-12-31 | $51.67 M | 1006.64% |
2020-12-31 | $4.66 M | -2.31% |
2019-12-31 | $4.78 M | -29.77% |
2018-12-31 | $6.8 M | -9.97% |
2017-12-31 | $7.55 M | 16845.01% |
2016-12-31 | $0.04 M | -99.94% |
2015-12-31 | $75.9 M | 48.33% |
2014-12-31 | $51.17 M | 832.47% |
2013-12-31 | $5.48 M | -67.15% |
2012-12-31 | $16.7 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.31 B | 8,625.22% | ๐บ๐ธ USA |